199 related articles for article (PubMed ID: 35058484)
1. Rational design of a helical peptide inhibitor targeting c-Myb-KIX interaction.
Suetaka S; Oka Y; Kunihara T; Hayashi Y; Arai M
Sci Rep; 2022 Jan; 12(1):816. PubMed ID: 35058484
[TBL] [Abstract][Full Text] [Related]
2. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.
Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000
[TBL] [Abstract][Full Text] [Related]
3. Structural and mechanistic insights into the interaction of the circadian transcription factor BMAL1 with the KIX domain of the CREB-binding protein.
Garg A; Orru R; Ye W; Distler U; Chojnacki JE; Köhn M; Tenzer S; Sönnichsen C; Wolf E
J Biol Chem; 2019 Nov; 294(45):16604-16619. PubMed ID: 31515273
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of binding of the KIX domain to the mixed lineage leukemia protein and its allosteric role in the recognition of c-Myb.
Toto A; Giri R; Brunori M; Gianni S
Protein Sci; 2014 Jul; 23(7):962-9. PubMed ID: 24753318
[TBL] [Abstract][Full Text] [Related]
5. Uncoupling the Folding and Binding of an Intrinsically Disordered Protein.
Poosapati A; Gregory E; Borcherds WM; Chemes LB; Daughdrill GW
J Mol Biol; 2018 Aug; 430(16):2389-2402. PubMed ID: 29890118
[TBL] [Abstract][Full Text] [Related]
6. Rational peptide design for inhibition of the KIX-MLL interaction.
Sato N; Suetaka S; Hayashi Y; Arai M
Sci Rep; 2023 Apr; 13(1):6330. PubMed ID: 37072438
[TBL] [Abstract][Full Text] [Related]
7. Conformational propensities of intrinsically disordered proteins influence the mechanism of binding and folding.
Arai M; Sugase K; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9614-9. PubMed ID: 26195786
[TBL] [Abstract][Full Text] [Related]
8. A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb.
Joy ST; Henley MJ; De Salle SN; Beyersdorf MS; Vock IW; Huldin AJL; Mapp AK
J Am Chem Soc; 2021 Sep; 143(37):15056-15062. PubMed ID: 34491719
[TBL] [Abstract][Full Text] [Related]
9. Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb.
Zor T; De Guzman RN; Dyson HJ; Wright PE
J Mol Biol; 2004 Mar; 337(3):521-34. PubMed ID: 15019774
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for cooperative regulation of KIX-mediated transcription pathways by the HTLV-1 HBZ activation domain.
Yang K; Stanfield RL; Martinez-Yamout MA; Dyson HJ; Wilson IA; Wright PE
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10040-10045. PubMed ID: 30232260
[TBL] [Abstract][Full Text] [Related]
11. Conformational control of the binding of the transactivation domain of the MLL protein and c-Myb to the KIX domain of CREB.
Korkmaz EN; Nussinov R; Haliloğlu T
PLoS Comput Biol; 2012; 8(3):e1002420. PubMed ID: 22438798
[TBL] [Abstract][Full Text] [Related]
12. Structure of the transition state for the binding of c-Myb and KIX highlights an unexpected order for a disordered system.
Giri R; Morrone A; Toto A; Brunori M; Gianni S
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14942-7. PubMed ID: 23980173
[TBL] [Abstract][Full Text] [Related]
13. Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain.
Goto NK; Zor T; Martinez-Yamout M; Dyson HJ; Wright PE
J Biol Chem; 2002 Nov; 277(45):43168-74. PubMed ID: 12205094
[TBL] [Abstract][Full Text] [Related]
14. Prepaying the entropic cost for allosteric regulation in KIX.
Law SM; Gagnon JK; Mapp AK; Brooks CL
Proc Natl Acad Sci U S A; 2014 Aug; 111(33):12067-72. PubMed ID: 25002472
[TBL] [Abstract][Full Text] [Related]
15. Roles of phosphorylation and helix propensity in the binding of the KIX domain of CREB-binding protein by constitutive (c-Myb) and inducible (CREB) activators.
Zor T; Mayr BM; Dyson HJ; Montminy MR; Wright PE
J Biol Chem; 2002 Nov; 277(44):42241-8. PubMed ID: 12196545
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for cooperative transcription factor binding to the CBP coactivator.
De Guzman RN; Goto NK; Dyson HJ; Wright PE
J Mol Biol; 2006 Feb; 355(5):1005-13. PubMed ID: 16253272
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the promiscuous interactions between intrinsically disordered transactivation domains and the KIX domain.
Huang Y; Gao M; Yang F; Zhang L; Su Z
Proteins; 2017 Nov; 85(11):2088-2095. PubMed ID: 28786199
[TBL] [Abstract][Full Text] [Related]
18. Leu628 of the KIX domain of CBP is a key residue for the interaction with the MLL transactivation domain.
Arai M; Dyson HJ; Wright PE
FEBS Lett; 2010 Nov; 584(22):4500-4. PubMed ID: 20969867
[TBL] [Abstract][Full Text] [Related]
19. Genetic interaction between mutations in c-Myb and the KIX domains of CBP and p300 affects multiple blood cell lineages and influences both gene activation and repression.
Kasper LH; Fukuyama T; Lerach S; Chang Y; Xu W; Wu S; Boyd KL; Brindle PK
PLoS One; 2013; 8(12):e82684. PubMed ID: 24340053
[TBL] [Abstract][Full Text] [Related]
20. Design and Biochemical Characterization of Peptidic Inhibitors of the Myb/p300 Interaction.
Jones M; Grosche P; Floersheimer A; André J; Gattlen R; Oser D; Tinchant J; Wille R; Chie-Leon B; Gerspacher M; Ertl P; Ostermann N; Altmann E; Manchado E; Vorherr T; Chène P
Biochemistry; 2023 Apr; 62(7):1321-1329. PubMed ID: 36883372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
